Founded in October 2019
The Swiss NASH Foundation was launched in October 2019 in Bern, Switzerland. In a joint effort to tackle the prevalence and burden of NASH, scientific experts and the leading pharmaceutical companies: Gilead, Allergan, Genfit and Intercept have joined forces to establish the foundation.
Swiss NASH Day
Swiss NASH Day is dedicated to increasing awareness about NASH and is scheduled the same week as the international NASH day. The Swiss NASH foundation is organising an event that will bring together different scientific and medical experts to discuss the latest advances in NASH research, treatment and patient management.
NASH is a worldwide epidemic disease affecting over 115 million people. Still, NASH remains an underdiagnosed and consequently an underreported disease. Untreated NASH may lead to cirrhosis, liver cancer and liver transplantation.
The Swiss NASH Foundation is a non-for-profit organization committed to the dissemination of knowledge and raising of awareness about NASH. Through funding cutting edge research projects and increasing the knowledge and awareness about NASH, the foundation aims at contributing to treatment discovery as well as improving the patients’ quality of life.
In a joint effort to tackle the increasing prevalence and burden of NASH, scientific experts and the leading pharmaceutical companies: Gilead, Allergan, Genfit and Intercept have joined forces to establish The Swiss NASH Foundation.
Prevent, diagnose and cure NASH.
Find out more
- International Nash Day aheadOn June 6th the International Nash Day organised by the Global Liver Institute is happening and we from the Swiss Nash Foundation are taking part […]
- AASLDs Liver Meeting 2021 is coming up!From November 12th till 15th 2021 the annual Liver Meeting organised by the AASLD – American Association for the Study of Liver Diseases is coming […]
- Omega 3 and NASH
What is NASH?
Non-alcoholic steatohepatitis (NASH) is the consequence of abnormal fat accumulation in the liver leading to liver inflammation and damage. It is the most severe form of non-alcoholic liver disease (NAFLD), commonly called “fatty liver”. NASH is a worldwide epidemic disease affecting over 115 million people. Still, NASH remains an under-diagnosed and consequently an underreported disease.Find out more >
Living with NASH
Many people live with NASH without knowing that they have a liver disease. The quality of life of these persons might be reduced due to their liver condition. Lifestyles can do a lot to improve NASH. Changes in diet habits, regular physical activity are measures which can improve if not cure NASH.Find out more >